Principal Financial Group Inc Sangamo Therapeutics, Inc Transaction History

Principal Financial Group Inc

  • $172 Billion
  • Q4 2024

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024
SELL
$0.36 - $0.65 $14,227 - $25,689
-39,522 Reduced 75.13%
13,083 $4,000
Q1 2024

Apr 29, 2024
BUY
$0.42 - $1.38 $905 - $2,976
2,157 Added 4.28%
52,605 $35,000
Q4 2023

Feb 07, 2024
SELL
$0.3 - $0.63 $1,066 - $2,240
-3,556 Reduced 6.58%
50,448 $27,000
Q3 2023

Nov 02, 2023
BUY
$0.58 - $1.47 $1,806 - $4,579
3,115 Added 6.12%
54,004 $32,000
Q2 2023

Aug 07, 2023
BUY
$1.11 - $1.74 $13,080 - $20,504
11,784 Added 30.13%
50,889 $66,000
Q1 2023

May 09, 2023
BUY
$1.66 - $3.67 $7,089 - $15,674
4,271 Added 12.26%
39,105 $68,000
Q4 2022

Feb 09, 2023
BUY
$2.77 - $5.07 $12,586 - $23,038
4,544 Added 15.0%
34,834 $109,000
Q3 2022

Nov 09, 2022
BUY
$4.27 - $6.39 $29,881 - $44,717
6,998 Added 30.04%
30,290 $149,000
Q2 2022

Aug 10, 2022
SELL
$3.28 - $6.21 $44,903 - $85,014
-13,690 Reduced 37.02%
23,292 $97,000
Q1 2022

May 09, 2022
BUY
$5.23 - $7.82 $2,395 - $3,581
458 Added 1.25%
36,982 $215,000
Q4 2021

Feb 09, 2022
SELL
$7.29 - $10.97 $111,879 - $168,356
-15,347 Reduced 29.59%
36,524 $273,000
Q3 2021

Nov 09, 2021
BUY
$9.01 - $12.01 $4,964 - $6,617
551 Added 1.07%
51,871 $467,000
Q2 2021

Aug 10, 2021
SELL
$10.17 - $12.64 $46,426 - $57,701
-4,565 Reduced 8.17%
51,320 $614,000
Q1 2021

May 10, 2021
SELL
$10.88 - $17.05 $25,959 - $40,681
-2,386 Reduced 4.09%
55,885 $700,000
Q4 2020

Feb 08, 2021
BUY
$9.23 - $18.18 $159,725 - $314,604
17,305 Added 42.24%
58,271 $909,000
Q3 2020

Nov 06, 2020
SELL
$9.38 - $12.48 $26,329 - $35,031
-2,807 Reduced 6.41%
40,966 $387,000
Q2 2020

Aug 05, 2020
BUY
$6.21 - $11.83 $73,321 - $139,676
11,807 Added 36.94%
43,773 $392,000
Q1 2020

May 12, 2020
BUY
$5.05 - $8.85 $6,923 - $12,133
1,371 Added 4.48%
31,966 $204,000
Q4 2019

Feb 05, 2020
SELL
$8.03 - $11.7 $8,479 - $12,355
-1,056 Reduced 3.34%
30,595 $256,000
Q3 2019

Nov 13, 2019
BUY
$9.05 - $12.22 $31,303 - $42,268
3,459 Added 12.27%
31,651 $286,000
Q2 2019

Aug 12, 2019
SELL
$8.75 - $13.03 $10,613 - $15,805
-1,213 Reduced 4.13%
28,192 $304,000
Q1 2019

May 10, 2019
BUY
$7.72 - $12.81 $10,059 - $16,691
1,303 Added 4.64%
29,405 $281,000
Q4 2018

Feb 14, 2019
SELL
$9.51 - $16.6 $522,260 - $911,622
-54,917 Reduced 66.15%
28,102 $322,000
Q3 2018

Nov 14, 2018
BUY
$13.05 - $19.05 $73,341 - $107,061
5,620 Added 7.26%
83,019 $1.41 Million
Q2 2018

Aug 13, 2018
BUY
$13.9 - $19.8 $318,574 - $453,796
22,919 Added 42.07%
77,399 $0
Q1 2018

May 14, 2018
BUY
$16.7 - $26.35 $65,297 - $103,028
3,910 Added 7.73%
54,480 $1.04 Million
Q4 2017

Feb 13, 2018
BUY
$11.6 - $17.35 $458,153 - $685,255
39,496 Added 356.66%
50,570 $829,000
Q3 2017

Nov 02, 2017
BUY
$8.4 - $15.0 $93,021 - $166,110
11,074
11,074 $166,000

Others Institutions Holding SGMO

# of Institutions
113
Shares Held
57.8M
Call Options Held
576K
Put Options Held
1.17M
View Full List

About SANGAMO THERAPEUTICS, INC

SGMO Quotes by TradingView
  • Ticker SGMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 156,552,992
  • Market Cap $182M
  • Description
  • Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...
More about SGMO
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email